Detalhe da pesquisa
1.
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination.
Nat Immunol
; 25(4): 633-643, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38486021
2.
Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response.
Nat Immunol
; 24(11): 1933-1946, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37828378
3.
Innate immune mechanisms of mRNA vaccines.
Immunity
; 55(11): 1993-2005, 2022 11 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36351374
4.
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.
Immunity
; 54(12): 2877-2892.e7, 2021 12 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34852217
5.
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation.
Immunity
; 53(6): 1281-1295.e5, 2020 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33296685
6.
The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans.
Immunity
; 52(5): 842-855.e6, 2020 05 19.
Artigo
Inglês
| MEDLINE | ID: mdl-32353250
7.
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
Immunity
; 53(4): 724-732.e7, 2020 10 13.
Artigo
Inglês
| MEDLINE | ID: mdl-32783919
8.
Molecular fate-mapping of serum antibody responses to repeat immunization.
Nature
; 615(7952): 482-489, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36646114
9.
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.
Nature
; 594(7864): 553-559, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33971664
10.
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.
Immunity
; 55(6): 1136-1138, 2022 Jun 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35704995
11.
Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria.
Nature
; 582(7810): 104-108, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32427965
12.
mRNA-LNP vaccine-induced CD8+ T-cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies.
Mol Ther
; 2024 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38605519
13.
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.
Proc Natl Acad Sci U S A
; 119(45): e2206333119, 2022 11 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36322769
14.
mRNA Vaccines in the COVID-19 Pandemic and Beyond.
Annu Rev Med
; 73: 17-39, 2022 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34669432
15.
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.
J Virol
; 97(1): e0172322, 2023 01 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36533954
16.
Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
J Virol
; 97(3): e0166422, 2023 03 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36779758
17.
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease.
Mol Ther
; 31(9): 2702-2714, 2023 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37533256
18.
Nucleoside-Modified mRNA Vaccines Protect IFNAR-/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection.
J Virol
; 96(3): e0156821, 2022 02 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34817199
19.
Messenger RNA-Based Vaccines Against Infectious Diseases.
Curr Top Microbiol Immunol
; 440: 111-145, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-32300916
20.
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination.
Nature
; 543(7644): 248-251, 2017 03 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28151488